Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model

• Published in: Antiviral research 2002-12, Vol.56 (3), p.263-272
• Main Authors: Fraternale, A, Casabianca, A, Orlandi, C, Cerasi, A, Chiarantini, L, Brandi, G, Magnani, M
• Format: Article
• Language: English
• Subjects: Animals; Anti-HIV Agents - administration & dosage; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral agents; AZT; Biological and medical sciences; DDI; Didanosine - administration & dosage; DNA, Viral - blood; Drug Therapy, Combination; Erythrocytes - metabolism; Female; Glutathione - administration & dosage; GSH-loaded erythrocytes; Hypergammaglobulinemia - virology; Lymphatic Diseases - virology; Lymphocytes - metabolism; Lymphocytes - virology; Macrophages; Macrophages - metabolism; Macrophages - virology; Medical sciences; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome - drug therapy; Murine Acquired Immunodeficiency Syndrome - virology; Murine AIDS; Pharmacology. Drug treatments; Reverse Transcriptase Inhibitors - administration & dosage; Splenomegaly - virology; Zidovudine - administration & dosage
• ISSN: 0166-3542; 1872-9096
• DOI: 10.1016/S0166-3542(02)00128-6

Monocyte-macrophages play a central role in HIV-1 infection because they are among the first cells to be infected and because later they are important reservoirs for the virus. Thus, newly designed therapies should take into account the protection of this cell compartment. Herein, we report the results obtained in a murine AIDS model, by the addition to AZT+DDI of a system (GSH-loaded erythrocytes) able to protect macrophages against HIV-1 infection. Five groups of LP-BM5-infected mice were treated as follows: one group was treated by AZT, one group was treated by DDI, one group was treated by the combination of both, another by GSH-loaded erythrocytes, and finally, one by the combination of all three. After 10 weeks of infection the parameters of the disease were studied and the proviral DNA content in different organs and in macrophages of bone marrow and of the peritoneal cavity was quantified. The results obtained show that mice treated with AZT+DDI+GSH-loaded erythrocytes showed proviral DNA content in the brain and in macrophages of bone marrow that was significantly lower than in mice treated with AZT+DDI. This study may help developing strategies aimed at blocking HIV-1 replication in its reservoirs in the body.